๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Malignant Tumors
Clinical trial register · China

Malignant Tumors Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 3 Beijing 3 Chengdu 3 Guangzhou 2 Wuhan 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai3 Beijing3 Chengdu3 Guangzhou2 Wuhan2
All 11 locations
Target enrolment
to

Malignant Tumors trials in China

13 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
NCT07622667Malignant Tumors
Nanfang Hospital, Southern Medical University
Observational
500
Guangzhou
2026-05-29
Not yet open
125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors
NCT07277777Malignant Tumors
Li Min
Phase 2
90
Jinan
2026-01
Not yet open
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
NCT07201259Malignant Tumors
West China Second University Hospital
Observational
40
Chengdu
2025-10-10
Recruiting
A Study of LM-350 in Subjects With Advanced Solid Tumours
NCT07112222Malignant Tumors
LaNova Medicines Limited
Phase 1/2
80
Beijing
2025-08-28
Recruiting
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
NCT07301801Malignant Tumors, SSTR2, PET
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
10
Wuhan
2025-06-12
Recruiting
Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies
NCT07004244Malignant Tumors
Sichuan University
Phase 1
20
Chengdu
2025-06-05
Recruiting
A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors
NCT06944444Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
154
Shanghai
2025-04-27
Not yet open
Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study
NCT06753513Malignant Tumors, Solid Tumor Malignancy
Zhejiang University
Observational
20
Hangzhou
2024-12-28
Recruiting
Study of LM-299 in Subjects Advanced Malignant Tumors
NCT06650566Malignant Tumors
LaNova Medicines Limited
Phase 1/2
108
Xinxiang, Liaocheng, Zibo, Shanghai
2024-10-09
Active, closed
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
NCT05714748Malignant Tumors
West China Hospital
Phase 1
19
Chengdu
2023-02-08
Recruiting
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
NCT05615974Malignant Tumors
LaNova Medicines Limited
Phase 1/2
139
Guangzhou, Wuhan, Linyi, Beijing, Shanghai
2023-01-11
By invitation
Chinese Population Health and Multimorbidity Study
NCT07026370Chronic Respiratory Diseases, Cardiovascular and Cerebrovascular Diseases, Malignant Tumors, Endocrine and Metabolic Diseases
China-Japan Friendship Hospital
Observational
50,991
Beijing
2011-01-01
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/malignant-tumors

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Malignant Tumors.

How many Malignant Tumors trials are recruiting in China?

7 of the 13 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Malignant Tumors), 13 studies
PhaseStudiesRecruitingShare
Observational4130.8%
Phase 13223.1%
Phase 1/23323.1%
Not applicable107.7%
Phase 2107.7%
Phase EARLY_PHASE1117.7%

Most active sponsors

Lead sponsors with the most studies (Malignant Tumors)
Lead sponsorStudiesRecruiting
LaNova Medicines Limited33
Li Min20
China-Japan Friendship Hospital10
Nanfang Hospital, Southern Medical University11
Shenyang Sunshine Pharmaceutical Co., LTD.11
Sichuan University11
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology11
West China Hospital10
West China Second University Hospital10
Zhejiang University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.